These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones. Guo Y, Wang S, Hoot DR, Clinton SK. J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033 [Abstract] [Full Text] [Related]
5. A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma. Das B, Yeger H, Tsuchida R, Torkin R, Gee MF, Thorner PS, Shibuya M, Malkin D, Baruchel S. Cancer Res; 2005 Aug 15; 65(16):7267-75. PubMed ID: 16103078 [Abstract] [Full Text] [Related]
15. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis. Bae DG, Kim TD, Li G, Yoon WH, Chae CB. Clin Cancer Res; 2005 Apr 01; 11(7):2651-61. PubMed ID: 15814646 [Abstract] [Full Text] [Related]
16. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells. Aesoy R, Sanchez BC, Norum JH, Lewensohn R, Viktorsson K, Linderholm B. Mol Cancer Res; 2008 Oct 01; 6(10):1630-8. PubMed ID: 18922978 [Abstract] [Full Text] [Related]
17. Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP. Guan F, Villegas G, Teichman J, Mundel P, Tufro A. Am J Physiol Renal Physiol; 2006 Aug 01; 291(2):F422-8. PubMed ID: 16597608 [Abstract] [Full Text] [Related]
18. [Autocrine stimulation of receptor-tyrosine kinases (RTK) in human tumor cell lines in vitro: therapeutic implications]. Gaumann A, Groot M, Drexler HC, Breier G. Verh Dtsch Ges Pathol; 2003 Aug 01; 87():232-9. PubMed ID: 16888917 [Abstract] [Full Text] [Related]